These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9100817)

  • 21. Evaluation of seven in vitro alternatives for ocular safety testing.
    Bruner LH; Kain DJ; Roberts DA; Parker RD
    Fundam Appl Toxicol; 1991 Jul; 17(1):136-49. PubMed ID: 1916072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic-based non-animal assessment of eye toxicity: Inflammatory profile of human keratinocytes cells after exposure to eye damage/irritant agents.
    da Silva ACG; Chialchia AR; de Ávila RI; Valadares MC
    Chem Biol Interact; 2018 Aug; 292():1-8. PubMed ID: 29953848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular viability and death biomarkers enables the evaluation of ocular irritation using the bovine corneal opacity and permeability assay.
    Xie Z; Ye K; Chen SH; Liu L; He LC; Sang J; Meng H; Kuang R
    Toxicol Lett; 2021 Apr; 340():52-57. PubMed ID: 33421553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition.
    Debbasch C; Ebenhahn C; Dami N; Pericoi M; Van den Berghe C; Cottin M; Nohynek GJ
    Food Chem Toxicol; 2005 Jan; 43(1):155-65. PubMed ID: 15582208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals.
    Stobbe JL; Drake KD; Maier KJ
    Int J Toxicol; 2003; 22(2):99-107. PubMed ID: 12745991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-house validation of the EpiOcular(TM) eye irritation test and its combination with the bovine corneal opacity and permeability test for the assessment of ocular irritation.
    Kolle SN; Kandárová H; Wareing B; van Ravenzwaay B; Landsiedel R
    Altern Lab Anim; 2011 Sep; 39(4):365-87. PubMed ID: 21942548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extent of initial corneal injury as a basis for alternative eye irritation tests.
    Jester JV; Li L; Molai A; Maurer JK
    Toxicol In Vitro; 2001 Apr; 15(2):115-30. PubMed ID: 11287171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: "Comparison of in vivo (Draize method) and in vitro (Corrositex assay) dermal corrosion values for selected industrial chemicals".
    Ulmer WR
    Int J Toxicol; 2003; 22(6):475-6; author response 476-8. PubMed ID: 14680995
    [No Abstract]   [Full Text] [Related]  

  • 29. Statistical planning and analysis considerations in the evaluation of in vitro alternatives to whole animal use for eye irritation testing.
    Feder P; Carr G; Holzhütter HG; Lovell D; Springer J
    Food Chem Toxicol; 1997 Jan; 35(1):167-74. PubMed ID: 9100820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative methods for the replacement of eye irritation testing.
    Lotz C; Schmid FF; Rossi A; Kurdyn S; Kampik D; De Wever B; Walles H; Groeber FK
    ALTEX; 2016; 33(1):55-67. PubMed ID: 26626125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-laboratory study of short time exposure (STE) test for predicting eye irritation potential of chemicals and correspondence to globally harmonized system (GHS) classification.
    Takahashi Y; Hayashi T; Watanabe S; Hayashi K; Koike M; Aisawa N; Ebata S; Sakaguchi H; Nakamura T; Kuwahara H; Nishiyama N
    J Toxicol Sci; 2009 Dec; 34(6):611-26. PubMed ID: 19952497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human hemoglobin denaturation as an alternative to the Draize test for predicting eye irritancy of surfactants.
    Mitjans M; Infante MR; Vinardell MP
    Regul Toxicol Pharmacol; 2008 Nov; 52(2):89-93. PubMed ID: 18602964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CON4EI: CONsortium for in vitro Eye Irritation testing strategy - EpiOcular™ time-to-toxicity (EpiOcular ET-50) protocols for hazard identification and labelling of eye irritating chemicals.
    Kandarova H; Letasiova S; Adriaens E; Guest R; Willoughby JA; Drzewiecka A; Gruszka K; Alépée N; Verstraelen S; Van Rompay AR
    Toxicol In Vitro; 2018 Jun; 49():34-52. PubMed ID: 28866024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of SV40 T-transformed human corneal epithelial cells to evaluate potential irritant chemicals for in vitro alternative eye toxicity.
    Kim CW; Park GT; Bae ON; Noh M; Choi KC
    J Pharmacol Toxicol Methods; 2016; 80():82-9. PubMed ID: 27233534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test.
    Spielmann H; Hoffmann S; Liebsch M; Botham P; Fentem JH; Eskes C; Roguet R; Cotovio J; Cole T; Worth A; Heylings J; Jones P; Robles C; Kandárová H; Gamer A; Remmele M; Curren R; Raabe H; Cockshott A; Gerner I; Zuang V
    Altern Lab Anim; 2007 Dec; 35(6):559-601. PubMed ID: 18186667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro tier evaluation for the identification of cosmetic ingredients which are not ocular irritants.
    Hagino S; Okazaki Y; Itagaki H
    Altern Lab Anim; 2008 Dec; 36(6):641-52. PubMed ID: 19154091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine Corneal Ocular Reversibility Assay (PorCORA) predicts ocular damage and recovery for global regulatory agency hazard categories.
    Piehl M; Carathers M; Soda R; Cerven D; DeGeorge G
    Toxicol In Vitro; 2011 Dec; 25(8):1912-8. PubMed ID: 21708243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of biomacromolecular in vitro assay systems in the prediction of in vivo toxic responses.
    Gordon VC
    Lens Eye Toxic Res; 1992; 9(3-4):211-27. PubMed ID: 1301782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.